University Research Highlights — 2026-03-22

---

Headline Breakthroughs

---

Scientists Inject One Tumor — and Watch Cancer Vanish Across the Body

• University / Institution: Researchers collaborating with Memorial Sloan Kettering and Duke University (led by Jeffrey Ravetch's group)
• Published in: ScienceDaily (reported March 15, 2026)
• The Discovery: Researchers engineered a more powerful CD40 agonist antibody and changed how it is delivered — injecting it directly into tumors rather than into the bloodstream. The redesigned immunotherapy showed striking early results after decades of disappointment with similar drugs. Crucially, researchers detected tertiary lymphoid structures (TLS) even in tumors that were not directly injected, suggesting the immune system, once activated, migrates to attack distant cancer sites.
• Why It Matters: This approach could transform how cancer immunotherapy is administered, potentially unlocking systemic anti-tumor immune responses from a single localized injection. Patients with multiple tumors could benefit from treatment at just one site.
• What's Next: Ravetch's group is now collaborating with scientists at Memorial Sloan Kettering and Duke University to further evaluate the therapy in additional clinical trials.

---

Ultra-Cool Step Toward Transformative Technologies: Harvard Physicists Advance Superconductivity Research

• University / Institution: Harvard University
• Published in: Harvard Gazette (reported March 19, 2026)
• The Discovery: Harvard physicists gained a new window into superconductivity by improving a device originally pioneered by Harvard Nobelist Percy Bridgman. The enhanced instrument allows researchers to study superconducting phenomena under conditions previously inaccessible, deepening understanding of how materials lose all electrical resistance.
• Why It Matters: Superconductivity underpins transformative technologies — from MRI machines and maglev trains to quantum computers. Better tools to study it could accelerate the development of room-temperature superconductors, one of physics' most coveted goals.
• What's Next: The Harvard team's improved device is expected to enable a new generation of experiments probing the quantum mechanics of superconducting materials.

---

Failed Experiment Leads to Surprise Drug Development Breakthrough

• University / Institution: University of Cambridge
• Published in: Nature Synthesis
• The Discovery: Scientists developed a new method to alter complex drug molecules using light rather than toxic chemicals. What began as a failed experiment led the team to discover what they call a fundamentally new photochemical approach to modifying molecular structures — a technique that could change how medicines are designed and manufactured.
• Why It Matters: Current drug modification methods often require hazardous reagents that add cost, waste, and safety concerns to pharmaceutical manufacturing. A light-based approach could make drug development cleaner, faster, and more accessible globally.
• What's Next: The Cambridge team is exploring how their photochemical method can be applied to a broader library of drug candidates currently in development pipelines.

---

Medical & Health Research

• Textbooks Were Wrong — New Understanding of How Human Hair Actually Grows — Queen Mary University of London & L'Oréal Research: Researchers used advanced 3D live imaging to observe individual cells inside living human hair follicles maintained in laboratory culture, revealing growth mechanisms that contradict longstanding textbook descriptions. The findings could reshape approaches to treating hair loss conditions.

• A New Model for Medical Discovery Using Existing Data — Duke University: Duke researchers are working to leverage existing clinical data to dramatically speed the process of finding medical answers, with the goal of reducing the time clinical studies take from up to a decade to a far shorter timeline.

• Smart Underwear Measures Gut Health in Real Time — Research team (via ScienceDaily): Researchers created "Smart Underwear," a wearable device that measures flatulence by detecting hydrogen produced by gut microbes. Early tests suggest people may pass gas about 32 times a day — far higher than previous estimates — opening new avenues for non-invasive gut microbiome monitoring.

---

Technology & Engineering

• Improved Bridgman-Type Device Unlocks New Superconductivity Experiments — Harvard University: Physicists improved an instrument pioneered by Nobel laureate Percy Bridgman to study superconductivity under previously unattainable conditions, potentially accelerating development of next-generation energy and quantum computing technologies.

• Photochemical Drug Modification: Light Replaces Toxic Reagents in Pharmaceutical Synthesis — University of Cambridge: Published in Nature Synthesis, this breakthrough photochemical technique enables precise alteration of complex drug molecules using only light, bypassing the hazardous chemicals that have long complicated pharmaceutical manufacturing.

---

Climate & Environment

No verified climate or environment research findings published after 2026-03-14 were available in this week's research results. This section will return next issue with fresh data.

---

What to Watch Next

• Cancer immunotherapy clinical trials at Memorial Sloan Kettering and Duke: The collaboration expanding on the CD40 agonist antibody tumor-injection results is underway now. Watch for early trial data on whether the systemic immune response holds across different cancer types and patient populations — this is one of the most consequential oncology readouts expected in the coming months.

• Key neurology trial readouts in early 2026: NeurologyLive is tracking multiple clinical trials with data readouts expected in the first half of 2026, spanning several neurological conditions. Researchers and clinicians following Parkinson's, Alzheimer's, and other neurodegenerative diseases should monitor these closely.

• Scientific fraud as an organized enterprise: A Northwestern University study released in early March found that academic fraud has evolved into a global, organized enterprise rather than isolated misconduct. As the research community digests these findings, expect ongoing debate about peer review reform, AI-assisted fraud detection, and journal integrity policies — a conversation that will shape how university research is validated for years to come.

---

Reader Action Items

• Read in full: The Nature Synthesis paper from the University of Cambridge on photochemical drug molecule modification — the methods section is particularly relevant for medicinal chemists and pharmaceutical engineers looking for greener synthesis pathways.

• Follow the data: The ScienceDaily report on the CD40 agonist antibody tumor-injection study contains detailed mechanistic descriptions of tertiary lymphoid structure (TLS) formation — a resource for immunologists tracking checkpoint and agonist antibody convergence.

• Question to follow: Does delivering immunotherapy directly into a single tumor reliably produce a systemic immune response across all tumor types, or only specific cancer subtypes? The Memorial Sloan Kettering / Duke collaboration will be the test case — and the answer could redefine oncology treatment protocols globally.